Detalhe da pesquisa
1.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Bioorg Med Chem Lett
; 19(3): 981-5, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095443
2.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Bioorg Med Chem Lett
; 19(3): 976-80, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095442
3.
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Bioorg Med Chem Lett
; 19(4): 1177-82, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19138846
4.
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.
J Med Chem
; 49(24): 7108-18, 2006 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17125263
5.
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
J Med Chem
; 46(4): 623-33, 2003 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-12570383
6.
Synthesis and activity of small molecule GPR40 agonists.
Bioorg Med Chem Lett
; 16(7): 1840-5, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16439116
7.
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
Bioorg Med Chem Lett
; 16(18): 4723-7, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16870432
8.
Brotes de ciguatera originados por jurel de la costa sur de Cuba / Outbreaks of ciguatera originated by jurel of the south coast of Cuba
Rev. cuba. hig. epidemiol
; 24(1): 78-85, ene.-mar. 1986. tab
Artigo
em Espanhol
| LILACS | ID: lil-52033